Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer [Phase 1]
A Phase 1 study evaluating the effect of lapatinib on the pharmacokinetics of digoxin in subjects with ErbB2/HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Rollover Study Of Lapatinib In Cancer Patients [Phase 1]
Phase 1 rollover study of lapatinib in cancer patients, including breast cancer, has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy [Phase 1]
Phase 1 trial evaluating Fosaprepitant dimeglumine with a Granisetron transdermal system to prevent chemotherapy-induced nausea and vomiting…
-
FDA approval · 2017-11-14FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Faslodex (fulvestrant) submitted by AstraZeneca Pharmaceuticals LP. This action updates the …
-
CLINICAL_TRIALS research · 2017-11-14Clinical Trial Update: A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer [Phase 1]
Phase 1 pharmacokinetic study evaluating the effect of esomeprazole on the pharmacokinetics of lapatinib in patients with metastatic HER2-po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Feasibility Study of Cavitary Radiofrequency Ablation in Excised Mastectomy Breast Tissue
The completed feasibility trial assessed whether cavitary radiofrequency ablation can be feasibly applied to excised breast tissue from prop…
-
CLINICAL_TRIALS research · 2017-11-14Clinical Trial Update: Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast Cancer [Phase 2]
A Phase 2 biomarker investigation study of neoadjuvant chemotherapy for breast cancer; the current trial status is listed as unknown.
-
CLINICAL_TRIALS research · 2017-11-14Clinical Trial Update: Superficial Serratus Plane Block for Modified Radical Mastectomy and Axillary Lymph Node Disection [NA]
A completed clinical trial evaluated the use of superficial serratus plane block for postoperative analgesia after modified radical mastecto…
-
CLINICAL_TRIALS withdrawal · 2017-11-14Clinical Trial Update: Genetic, Neurophysiological and Psychological Predictive Factors of Chronic Neuropathic Pain After Surgery for Breast Cancer [NA]
A clinical trial (NCT02944721) investigating genetic, neurophysiological, and psychological predictors of chronic neuropathic pain after bre…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer [Phase 3]
This Phase 3 trial comparing neoadjuvant chemo-endocrine therapy to chemotherapy alone in ER-positive, HER2-negative breast cancer has compl…
-
CLINICAL_TRIALS research · 2017-11-13Clinical Trial Update: A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib [Phase 1]
A completed Phase 1 study evaluated the bioequivalence of alternative formulations of Lapatinib in cancer patients.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer [Phase 1]
An exploratory Phase 1 PET imaging study of lapatinib in breast cancer patients; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer [Phase 1]
Phase 1 study evaluating the pharmacokinetics and pharmacodynamics of lapatinib given in two dosing regimens in treatment-naive breast cance…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors [Phase 1]
This is a Phase I, open-label study of pazopanib in combination with epirubicin or doxorubicin for advanced solid tumors, focusing on breast…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Neurovascular Changes Induced by Chemotherapy [NA]
This clinical trial update reports on neurovascular changes induced by chemotherapy in breast cancer patients, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Observational Trial on the Impact of Hypnose Used as a Sedation in Oncology Surgery in Breast Cancer
An observational trial evaluating hypnosis as a sedation method during breast cancer surgery has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab [Phase 4]
Phase 4 trial update describes patient preferences for combining everolimus with exemestane or capecitabine with bevacizumab in recurrent HE…
-
CLINICAL_TRIALS research · 2017-11-13Clinical Trial Update: A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients [Phase 1]
A Phase 1 clinical trial investigated the effect of low- and high-fat meals on the oral absorption of lapatinib in patients with metastatic …
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial update evaluating Gemcitabine with Trastuzumab and Gemcitabine with Cisplatin/Trastuzumab in metastatic breast cancer has comp…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer [Phase 2]
Phase 2 trial comparing neratinib to lapatinib plus capecitabine in ErbB2-positive advanced breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating neratinib in combination with capecitabine in solid tumors and breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Use of Low-dose Molecular Breast Imaging for the Detection of Small Breast Lesions
The document provides an update on a completed clinical trial evaluating low-dose molecular breast imaging for detecting small breast lesion…
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Capecitabine With Digoxin for Metastatic Breast Cancer [Phase 2]
Phase 2 trial updating capecitabine with digoxin for metastatic breast cancer; study terminated with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer [Phase 2]
Phase 2 trial evaluating hepatic artery infusion with FOLFOX for metastatic breast cancer; the study is terminated with results posted.
-
CLINICAL_TRIALS research · 2017-11-08Clinical Trial Update: Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer
This clinical trial update discusses a study focused on how women with newly diagnosed breast cancer decide whether to undergo genetic testi…